Background
Methods
Patient selection
Data collection
The criteria of diagnosing abnormal glycometabolism
Other variables definition
Outcome assessment
Statistical analysis
Results
Comparison of the characteristics of patients in different glucose metabolism groups
Clinic features | Diabetes mellitus (n = 1220) | Prediabetes (n = 777) | Normoglycemia (n = 910) |
P
|
---|---|---|---|---|
Age, y (median, Q1–3) | 64 (55, 73) | 61 (52,72) | 58 (49, 69)) | <0.001 |
Male, n (%) | 711(58.3) | 501 (64.5%) | 616 (67.7) | <0.001 |
Tobacco use, n (%) | 0.036 | |||
Never | 712 (58.4) | 428 (55.1) | 480 (52.7) | |
Quit | 110 (9.0) | 74 (9.5) | 79 (8.7) | |
Current | 351 (28.8) | 246 (31.7) | 320 (35.2) | |
Alcohol consumption, n (%) | 0.164 | |||
Mild | 213 (17.5) | 132 (17.0) | 171 (18.8) | |
Moderate to severe | 165 (13.5) | 131 (16.9) | 152 (16.7) | |
Never | 817 (67.0) | 494 (63.6) | 564 (62.0) | |
BMI, kg/m2 (median, Q1–3) | 25.0 (22.9,27.3) | 24.5 (22.5,26.8) | 24.2 (22.0,26.2) | <0.001 |
NIHSS (median,Q1-Q3) | 5 (2–9) | 5 (2,9) | 4 (2–8) | 0.002 |
Creatinine,m mol L−1 (median, Q1–3) | 71.2 (58.0, 87.0) | 72.0 (60.0, 87.0) | 71.8 (59.9, 86.7) | 0.425 |
LDL, m mol L−1 (median, Q1–3) | 3.0 (2.4, 3.6) | 2.9 (2.3, 3.5) | 2.8 (2.3, 3.4) | 0.001 |
HDL,m mol L−1(median, Q1–3) | 1.1(1.0, 1.3) | 1.2 (1.0, 1.4) | 1.2 (1.1, 1.4) | <0.001 |
Systolic blood pressure, mmHg (median, Q1–3) | 150 (138, 160) | 143 (130, 160) | 146 (130, 160) | <0.001 |
Homocysteine, μ mol L−1, (median, Q1–3) | 14.4 (11.5, 18.7) | 15.5 (12.0, 21.9) | 15.7 (12.3, 22.8) | <0.001 |
HOMA2-IR (median, Q1–3) | 2.5 (1.6, 4.0) | 1.9 (1.1, 3.0) | 1.6 (0.9, 2.5) | <0.001 |
Past medical history, yes, n (%) | ||||
Coronary artery disease | 172 (14.1) | 87 (11.2) | 90 (9.9) | 0.009 |
Hypertension | 795 (65.2) | 470 (60.5) | 514 (56.5) | <0.001 |
Atrial fibrillation | 66 (5.4) | 54 (6.9) | 31 (3.4) | 0.006 |
Stroke types, n (%) | <0.001 | |||
IS | 1015 (83.2) | 541 (69.6) | 675 (74.2) | |
ICH | 174 (14.3) | 185 (23.8) | 198 (21.8) | |
SAH | 31 (2.5) | 51 (6.6) | 37 (4.1) |
Comparison of the characteristics of patients with different functional outcomes of the stroke
Clinic features | Favorable outcomes (n = 1305) | Poor functional outcomes (n = 1602) |
P
|
---|---|---|---|
Age, y | 60 (52, 71) | 62 (53, 72) | 0.003 |
Male, n (%) | 954 (73.1) | 1089 (68.0) | <0.001 |
Tobacco use, n (%) | 0.036 | ||
Never | 692 (53.0) | 928 (57.9) | |
Quit | 126 (9.7) | 137 (8.6) | |
Current | 436 (33.4) | 481 (30.0) | |
Alcohol consumption, n (%) | 0.006 | ||
Never | 811 (62.1) | 1064 (66.4) | |
Mild | 266 (20.4) | 250 (15.6) | |
Moderate to severe | 192 (14.7) | 256 (16.0) | |
BMI(kg/m2) | 24.6 (22.5,26.7) | 24.5 (22.4,26.8) | 0.637 |
NIHSS scales | <0.001 | ||
<9 | 1256 (96.2) | 996 (62.2) | |
9–18 | 30 (2.3) | 474 (29.6) | |
> 18 | 7 (0.5) | 124 (7.7) | |
Creatinine (m mol L−1) | 72.7 (60.0, 87.5) | 70.0 (57.5,85.0) | 0.002 |
LDL(m mol L−1) | 2.8 (2.3,3.5) | 2.9 (2.3,3.5) | 0.290 |
HDL(m mol L−1) | 1.2 (1.0,1.4) | 1.2 (1.0,1.4) | 0.125 |
Systolic blood pressure (mmHg) | 140 (130,160) | 150 (134,161) | <0.001 |
Homocysteine (μmol L−1) | 14.6 (11.4,19.8) | 15.8 (12.3,21.4) | <0.001 |
HOMA2-IR | 1.8 (1.1,3.0) | 2.0 (1.2,3.1) | 0.055 |
Past medical history, yes, n (%) | |||
Coronary heart disease | 146 (11.2) | 203 (12.7) | 0.230 |
Hypertension | 785 (60.2) | 994 (62.0) | 0.296 |
Atrial fibrillation | 53 (4.1) | 98 (6.1) | 0.013 |
Stroke types, n (%) | <0.001 | ||
Ischemic stroke | 1059 (81.1) | 1172 (73.2) | <0.001 |
Cardioembolic | 44 (3.4) | 91 (5.7) | |
Large-artery atherosclerosis | 565 (43.3) | 819 (51.1) | |
Small-artery occlusion Lacunar | 367 (28.1) | 200 (12.5) | |
Other demonstrated or undemonstrated | 38 (2.9) | 25 (1.6) | |
ICH | 176 (13.5) | 381(23.8) | |
SAH | 70 (5.4) | 49 (3.1) | |
Glycometabolism status |
<0.001
| ||
Diabetes mellitus | 500 (38.3) | 720 (44.9) | |
Prediabetes | 348 (26.7) | 429 (26.8) | |
Normoglycaemia | 457 (35.0) | 453 (28.3) |
Analysis on medication use and SUA concentration
Correlation between SUA and poor functional outcome at discharge
Univariate analysis of SUA quartiles on poor outcome
Multivariate analysis of SUA quartiles on poor functional outcome at discharge
Multivariate analysis of SUA deciles on poor functional outcome
Multivariate analysis of continuous SUA concentration on poor functional outcome
Glycometabolism status | Odds ratio with 95% confidence intervals |
P
|
---|---|---|
Diabetes mellitus | 0.98 (0.97–1.00) | 0.135 |
Prediabetes | 1.00 (1.00–1.01) | 0.105 |
Normoglycaemia | 0.99 (0.98–1.00) | 0.022 |